Skip to main content
NIH funding notice PAR-22-147

Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional)

Closed on November 1, 2024.

Posted
April 8, 2022
Close date
November 1, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,380,243 in first-year total cost, median $544,745.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 SRB-X (M1)]4
  2. Special Emphasis Panel[ZCA1 SRB-X (J1)]3
  3. Special Emphasis Panel[ZCA1 SRB-X (J2)]1

Most frequent institutions

  1. BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
  2. CLEMSON UNIVERSITY1
  3. CLEVELAND CLINIC LERNER COM-CWRU1
  4. GEORGIA INSTITUTE OF TECHNOLOGY1
  5. NORTHEASTERN UNIVERSITY1
Competing awards under PAR-22-147 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Stiffness-mediated genetic selection of cells1U01CA283753-01A1GHAJAR, CYRUS MPEYTON, SHELLY R.TUFTS UNIVERSITY MEDFORD, MA$556,865ZCA1
2025Exploring the dynamic tumor-immune ecosystem of breast cancer in heterogeneous tumor microenvironments1U01CA293859-01A1FINLEY, STACEY DELERIAROUSSOS TORRES, EVANTHIA THEODOSIOUUNIVERSITY OF SOUTHERN CALIFORNIA, CA$531,693ZCA1
2025Flow-informed therapy for glioblastoma1U01CA305075-01MUNSON, JENNIFER MVIRGINIA POLYTECHNIC INST AND ST UNIV, VA$522,491ZCA1
2024State-transition and leukemia potential dynamics to inform disease evolution and adaptive therapy1U01CA293853-01KUO, YA-HUEIMARCUCCI, GUIDOROCKNE, RUSSELL CHRISTIANBECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA$590,960ZCA1
2024Cell State Network-Directed Therapy1U01CA290442-01A1BIRTWISTLE, MARC R.GALLO, JAMES M.LAO, YEH-HSINGCLEMSON UNIVERSITY, SC$558,333ZCA1
2023Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling1U01CA280829-01MARUSYK, ANDRIYSCOTT, JACOB GARDINIERCLEVELAND CLINIC LERNER COM-CWRU, OH$557,997ZCA1
2023Dysregulated mechanoimmunology of epigenetics-driven lymphomas1U01CA280984-01SINGH, ANKURZHU, CHENGGEORGIA INSTITUTE OF TECHNOLOGY, GA$532,624ZCA1
2023Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer1U01CA280849-01ENDERLING, HEIKOSPRING, BRYAN QUILTYNORTHEASTERN UNIVERSITY, MA$529,280ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-22-147: Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) | ScienceDex | ConductScience